Fosamax Cost in Louisiana 2026: What You Will Actually Pay for Alendronate

How Much Does Fosamax Cost in Louisiana Right Now?

Generic alendronate retails for approximately $15 per month at Louisiana pharmacies in 2026, making it one of the most affordable oral bisphosphonates available. Merck's branded Fosamax carries a list price near $80 per month, but fewer than 5% of Louisiana patients fill the brand when the generic is available at the same dose and bioequivalence standard.

The 70 mg once-weekly tablet is the most commonly dispensed form for postmenopausal osteoporosis treatment, and it is available from every major retail chain in Louisiana, including Walgreens, CVS, and Walmart pharmacy. Alendronate 70 mg tablets have been off-patent since 2008, which is the primary reason prices collapsed so dramatically from the original Fosamax launch price of well over $100 per month in the mid-1990s. [1]

Price variation across the state is real. A GoodRx search in New Orleans, Baton Rouge, and Shreveport in late 2025 showed a spread of roughly $9 to $22 per month for the 70 mg tablet depending on pharmacy and coupon applied. Costco and Sam's Club pharmacies, which are open to non-members for prescriptions in Louisiana under state law, tend to land at the low end of that range. [2]

Alendronate sodium 10 mg daily tablets, sometimes prescribed for men with osteoporosis or for daily dosing preference, run slightly higher at approximately $18 to $25 per month because they are dispensed in larger tablet counts. The 35 mg once-weekly dose for osteoporosis prevention in women with low bone density costs a similar $12 to $18 per month on the generic market. [3]

For clinical context: the Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027), demonstrated that alendronate reduced vertebral fracture risk by 47% over three years in women with existing vertebral fractures (relative risk 0.53 to 95% CI 0.41 to 0.68, P<0.001). [4] That fracture-reduction data is the foundation of every major prescribing guideline that makes alendronate a first-line agent, which in turn drives the enormous prescription volume that keeps generic prices low.

Does Louisiana Medicaid Cover Alendronate (Fosamax)?

Louisiana Medicaid does not currently cover alendronate for osteoporosis under its standard formulary. Patients enrolled in Louisiana Medicaid who have a diagnosis of osteoporosis or osteopenia are not automatically entitled to covered alendronate fills as of 2026.

This is a meaningful coverage gap. Louisiana ranks among the states with the highest rates of osteoporosis-related hip fractures per capita, particularly in rural parishes. [5] The American Association of Clinical Endocrinologists (AACE) 2020 guidelines list alendronate as a first-line agent for postmenopausal osteoporosis, noting its "strong antifracture efficacy at both vertebral and nonvertebral sites." [6] Denying Medicaid coverage for a $15-per-month generic with that evidence base is a policy inconsistency that advocates have raised repeatedly.

Workarounds exist. Louisiana Medicaid does cover alendronate in limited circumstances: patients with glucocorticoid-induced osteoporosis who meet specific diagnostic criteria may qualify under a different billing pathway. Medicaid managed care plans (Healthy Blue Louisiana, Aetna Better Health of Louisiana, AmeriHealth Caritas Louisiana, and Louisiana Healthcare Connections) each administer their own formularies, and individual managed care organization (MCO) coverage can differ from the base Medicaid fee-for-service policy. Patients should call the member services number on their Medicaid card and ask specifically about bisphosphonate coverage under their MCO plan before assuming denial. [7]

If coverage is denied, the $15 cash-pay price at retail is low enough that most patients spend less out of pocket paying cash than they would spend on prior authorization appeals and specialist visits required to document medical necessity. A 90-day supply at Walmart pharmacy in Louisiana runs approximately $35 to $40 without insurance, which is less than most Medicaid co-pays for brand drugs in other drug classes.

Which Private Insurance Plans Cover Alendronate in Louisiana?

Most commercial insurance plans in Louisiana cover generic alendronate on Tier 1 or Tier 2, meaning co-pays typically run $0 to $15 per 30-day fill. Blue Cross and Blue Shield of Louisiana, Humana, and UnitedHealthcare all place generic alendronate on their preferred generic tiers for members with a qualifying osteoporosis diagnosis. [8]

Branded Fosamax is rarely covered at preferred status. When it appears on formulary at all, it lands on Tier 3 or Tier 4, where co-pays can reach $50 to $100 per month even with insurance. Physicians prescribing for Louisiana patients should write "generic acceptable" (or submit the prescription as alendronate sodium rather than Fosamax) to avoid inadvertent brand dispenses.

Medicare Part D coverage for alendronate in Louisiana depends on plan selection. All Part D plans sold in Louisiana are required to cover at least one bisphosphonate on formulary under the CMS 2026 formulary guidelines. [9] Generic alendronate appears on the formulary of every Part D plan active in Louisiana in 2026. Most plans place it on Tier 1 with a $0 co-pay during the initial coverage phase, though patients in the coverage gap should verify their specific plan's tier structure at medicare.gov or by calling 1-800-MEDICARE.

Employer-sponsored plans follow their own formulary decisions. Employees at Louisiana state agencies are covered under the Office of Group Benefits (OGB) health plans. OGB's standard formulary includes generic alendronate at the preferred generic co-pay level, which for the Magnolia plan runs $10 per 30-day fill for in-network pharmacy use. [10]

Prior authorization is rarely required for generic alendronate by commercial plans in Louisiana, though some plans require a DEXA scan result (T-score of -2.5 or lower for treatment indication, or -1.0 to -2.5 for prevention indication) documented in the medical record before approving the first fill. The National Osteoporosis Foundation defines intervention thresholds that most Louisiana insurers use as their PA criteria. [11]

Is Compounded Alendronate Legal in Louisiana?

Compounded alendronate is legally available in Louisiana through state-licensed 503A compounding pharmacies. It is not available from FDA-registered 503B outsourcing facilities because alendronate is not on the FDA's drug shortage list and therefore does not meet the threshold required for 503B bulk compounding. [12]

A 503A pharmacy may legally compound alendronate for an individual patient when a licensed prescriber provides a valid patient-specific prescription. Louisiana's Board of Pharmacy regulates 503A compounders under state pharmacy law that aligns with USP Chapter 795 standards for non-sterile preparations. Alendronate compounded formulations include oral solutions and customized tablet strengths that may benefit patients who have difficulty swallowing standard tablets or who require doses not available commercially.

The cost of compounded alendronate varies by pharmacy and formulation. Some Louisiana compounding pharmacies offer alendronate preparations at effectively $0 to the patient when billed through specific programs or when provided as part of a bundled telehealth-and-pharmacy service. Patients should verify that any compounding pharmacy they use holds an active Louisiana Board of Pharmacy license, which can be confirmed at the Louisiana Board of Pharmacy's public license search portal.

Patients and prescribers should be aware that the FDA does not review compounded drug products for safety or efficacy, and bioavailability from compounded oral alendronate solutions has not been studied in large controlled trials the way the commercial tablet has been. The commercial 70 mg tablet's pharmacokinetics, including its approximately 0.7% absolute oral bioavailability in fasting adults, are the basis for the fracture reduction data from FIT and FLEX. [4]

Can You Get a Fosamax Prescription via Telehealth in Louisiana?

Telehealth prescribing of alendronate is fully permitted in Louisiana. A licensed Louisiana prescriber, including physicians, nurse practitioners, and physician assistants with prescriptive authority, may evaluate a patient via synchronous audio-video telehealth and issue an alendronate prescription. [13]

Louisiana follows the Ryan Haight Act's requirements for controlled substances, but alendronate is not a controlled substance, so the more restrictive telehealth rules do not apply. A prescriber conducting a good-faith evaluation via telehealth that includes review of bone density data (DEXA scan results), fracture history, and relevant labs (serum calcium, 25-OH vitamin D, creatinine) may issue a prescription under Louisiana state law without an in-person visit.

HealthRX's licensed Louisiana prescribers conduct osteoporosis evaluations via telehealth and can prescribe alendronate to qualifying patients. The standard evaluation includes review of DEXA T-scores, FRAX fracture risk calculation, vitamin D levels, and renal function before prescribing. Patients with a creatinine clearance below 35 mL/min should not receive alendronate according to the FDA prescribing label, and telehealth providers review renal labs as part of the eligibility screen. [14]

After a telehealth visit, the prescription is sent electronically to the patient's pharmacy of choice, including any Louisiana retail pharmacy or a licensed compounding pharmacy. Most patients see the prescription filled same-day or next-day.

What Are the Cheapest Ways to Get Alendronate in Louisiana?

Several overlapping cost-reduction options are available to Louisiana patients in 2026.

Generic cash-pay with GoodRx or similar coupons. Generic alendronate 70 mg with a GoodRx coupon at Walmart in Baton Rouge ran as low as $9 for a 30-day supply in late 2025. These coupons are free to use and do not require insurance enrollment. Patients should compare prices at GoodRx, RxSaver, and NeedyMeds before filling, because prices vary by pharmacy even within the same ZIP code. [15]

Manufacturer savings programs. Merck's Fosamax savings card is only useful if a patient is specifically prescribed branded Fosamax and is commercially insured. The savings card cannot be used with Medicare, Medicaid, or any federal health program under the federal anti-kickback statute. Most Louisiana patients have no financial reason to pursue branded Fosamax when the generic costs $15 or less per month on cash-pay.

Medicare Extra Help (Low-Income Subsidy). Louisiana patients enrolled in Medicare Part D who qualify for the Low-Income Subsidy program pay $0 to $4.50 for generic drugs at the lowest LIS tier in 2026. Alendronate qualifies. Eligibility is income-based and applications are processed through the Social Security Administration. [16]

Patient assistance programs. Merck's MSD patient assistance program covers branded Fosamax for uninsured patients who meet income criteria. Given the $15 generic price, this program is most useful for patients whose prescriber specifies a dose form only available in the brand or for whom the generic is unavailable locally.

503A compounding route. Some telehealth-and-compounding-pharmacy programs offer compounded alendronate at $0 to the patient, bundling the medication cost into a subscription or program fee. Patients should carefully read total cost terms to confirm the net cost is genuinely lower than the $15 generic retail price before switching to a compounded formulation.

The HealthRX Louisiana Alendronate Cost Decision Framework below summarizes the recommended pathway based on insurance status:

1. Commercially insured. Confirm alendronate is on Tier 1 or 2. If Tier 3 or higher, ask prescriber to submit a step-therapy or medical necessity form. Expected co-pay: $0 to $15.
2. Louisiana Medicaid (fee-for-service). Medicaid does not cover for standard osteoporosis indication. Pay $9 to $15 cash with GoodRx. Investigate MCO formulary differences if enrolled in a managed care plan.
3. Medicare Part D. Confirm plan formulary at medicare.gov. If LIS-eligible, apply for Extra Help. Expected co-pay: $0 to $10.
4. Uninsured. Use GoodRx or similar coupon at Walmart or Costco. Budget $9 to $18 per month. Reassess annually as prices shift.
5. Compounding interest. Only pursue 503A compounded alendronate if you have a documented intolerance to commercial tablet excipients or a prescriber-identified clinical need for a non-standard dose or formulation. Confirm the pharmacy holds an active Louisiana Board of Pharmacy license.

Understanding Alendronate Dosing and Adherence in Louisiana Patients

Alendronate is taken once weekly (70 mg for osteoporosis treatment, 35 mg for osteoporosis prevention) or daily (10 mg for treatment, 5 mg for prevention) as an oral tablet. The once-weekly formulation dominates prescriptions in Louisiana because weekly dosing improves adherence without sacrificing efficacy. [17]

Administration requires strict technique. Patients must take alendronate with a full 8-ounce glass of plain water, at least 30 minutes before any food, beverage, or other medication, and remain upright for at least 30 minutes afterward. Esophageal irritation and, rarely, esophageal ulceration are the most clinically significant GI adverse effects, and both are substantially reduced with correct administration technique. [14]

The FLEX trial (N=1,099) showed that women who had taken alendronate for five years and then stopped still maintained fracture protection for up to five additional years without continued treatment, suggesting a drug holiday may be appropriate for many patients after five years of continuous use. [18] This matters for Louisiana Medicaid patients facing coverage gaps: a one-year gap in therapy is unlikely to materially increase fracture risk in patients who have completed five years of treatment.

Vitamin D and calcium adequacy are prerequisites for alendronate to work properly. The Endocrine Society recommends that adults receiving bone-active agents maintain serum 25-OH vitamin D above 30 ng/mL and calcium intake of 1,000 to 1 to 200 mg per day from dietary and supplemental sources combined. [19] Louisiana prescribers should measure 25-OH vitamin D before initiating alendronate because vitamin D deficiency is common in Louisiana's older adult population. [20]

Rare but serious adverse effects include osteonecrosis of the jaw (ONJ) and atypical femoral fractures (AFF). The absolute risk of ONJ in patients taking oral alendronate for osteoporosis (as opposed to intravenous bisphosphonates for cancer indications) is approximately 1 in 10,000 to 1 in 100,000 patient-years, based on a 2009 systematic review published in JBMR. [21] Patients should inform their dentist before any invasive dental procedures.

Monitoring and Lab Requirements for Alendronate in Louisiana

Prescribers in Louisiana typically order the following before initiating alendronate: serum calcium, serum creatinine (to calculate creatinine clearance), and 25-OH vitamin D. A baseline DEXA scan is standard to confirm diagnosis and provide a reference point for monitoring response. [6]

Repeat DEXA is recommended at one to two years after initiation to assess response. After that, intervals of two to three years are generally sufficient for patients showing stable or improving bone mineral density. The FDA-approved indication requires a T-score at or below -2.5 at the lumbar spine or hip for treatment, or a T-score between -1.0 and -2.5 with additional fracture risk factors for prevention. [14]

DEXA scans are covered by Medicare Part B every 24 months for beneficiaries with osteoporosis risk factors, including patients already on pharmacotherapy. Louisiana commercial insurers follow similar intervals. The CMS national coverage determination for bone mass measurement is accessible on the CMS website and is the benchmark most Louisiana payers use. [22]

Serum bone turnover markers, specifically serum CTX (C-terminal telopeptide of type I collagen), can confirm biochemical response to alendronate within three to six months of initiation. A reduction in CTX of at least 25% from baseline suggests the patient is absorbing and responding to the medication. This test is not universally required but is useful in patients where adherence or absorption is uncertain. [23]

Side Effects Louisianans Should Know Before Starting

Upper GI symptoms are the most common reason patients in Louisiana stop alendronate prematurely. Heartburn, reflux, and esophageal discomfort occur in approximately 6% to 10% of patients in clinical trials. [24] Correct administration technique, as described above, reduces this substantially.

Musculoskeletal pain, including bone, joint, and muscle aches, was recognized in a 2008 FDA safety update as a potential adverse effect requiring monitoring. [25] The FDA label now carries a warning for severe and occasionally incapacitating musculoskeletal pain; prescribers should counsel patients to report new or worsening pain.

Hypocalcemia can occur, particularly in patients with vitamin D deficiency. Correcting vitamin D status before initiating alendronate is the standard approach recommended in the AACE guidelines and is especially relevant in Louisiana's elderly population, where deficiency prevalence may exceed 40% in some demographic groups. [20]

Atrial fibrillation was noted at slightly higher rates in the alendronate arm of FIT (1.5% vs. 1.0% in placebo) but has not been confirmed as a causal relationship in subsequent meta-analyses. A 2019 Cochrane review of bisphosphonate cardiovascular safety found no significant increase in atrial fibrillation risk attributable to oral bisphosphonates. [26]